COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia

The world is experiencing the COVID-19 outbreak and there are no evidence-based treatment strategies available for immunocompromised patients. COVID-19 is a novel beta coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with cancer are more susceptible to infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gesiotto, Quinto, Cheema, Asima, Avaiya, Kishan, Shah, Bijal, Greene, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231731/
https://www.ncbi.nlm.nih.gov/pubmed/34188994
http://dx.doi.org/10.7759/cureus.15256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231731/
https://www.ncbi.nlm.nih.gov/pubmed/34188994
http://dx.doi.org/10.7759/cureus.15256

Ejemplares similares